Tracy Pfeifer, MD sheds some light into the world of sunblock. Discussing both physical blocks and chemical blocks as well as SPF levels, Dr. Pfeifer gives her take as to what works best.
Melanoma immunotherapy has a critical limitation: 40 to 60% of patients don’t respond. Arielle Elkrief, MD, discusses an innovative approach targeting the gut microbiome. By using fecal microbiota…
Shereene Idriss, MD, dives into the causes and treatments for jowls, from natural aging and lifestyle habits to bone structure changes. Highlighting at-home remedies like facial massages and…
Muneeb Shah MD, and Luke Maxfield, MD, break down the essentials of skin cancer, explaining the causes, symptoms, and treatments of basal cell carcinoma, squamous cell carcinoma, and…
Melanoma immunotherapy has a critical limitation: 40 to 60% of patients don’t respond. Arielle Elkrief, MD, discusses an innovative approach targeting the gut microbiome. By using fecal microbiota…
Muneeb Shah MD, and Luke Maxfield, MD, break down the essentials of skin cancer, explaining the causes, symptoms, and treatments of basal cell carcinoma, squamous cell carcinoma, and…
The FDA has approved MTAV, a groundbreaking treatment for melanoma, a potentially deadly skin cancer. Known as tumor-infiltrating lymphocyte (TIL) therapy, this innovative approach uses a patient’s own…
Melanoma’s link to sun exposure may not be as straightforward as commonly thought. While outdoor workers have higher UV exposure, studies like a European case-control study and the…
Stanford Cancer Center is offering new hope to melanoma patients through a groundbreaking cellular therapy called tumor infiltrating lymphocyte (TIL) therapy. This is the first approved cellular therapy…
Allison Betof Warner, MD from Stanford Healthcare discusses recent advancements in treating advanced melanoma with a newly FDA-approved cell-based therapy. This innovative treatment is designed for patients who…
